Learn how to manage musculoskeletal pain in multiple sclerosis. Discover causes, symptoms, diagnosis, and effective treatment ...

Cladribine is linked to lower risk for disability progression in patients with relapsing-remitting multiple sclerosis vs ...

Today, a new approach is giving patients and their physicians reason to hope. Moffitt Cancer Center has expanded its ...

A groundbreaking new trial is set to investigate whether an mRNA jab, designed to target the Epstein-Barr virus (EBV), could ...

Tyruko, the first biosimilar of Tysabri, is now available in the U.S., providing a lower-cost treatment option for adults ...

In MS, immune system cells mistakenly attack myelin. With stem cell treatment, doctors use chemotherapy to destroy these existing immune cells. Then, they introduce the new stem cells, which are not ...

Roche Holding AG said a multiple sclerosis drug showed it could work for most forms of the disease in two late-stage trials, cutting the number of relapses compared to another treatment over nearly ...

Doctors are looking to recruit more people for the trial, which they say could one day be given as a single one-off treatment ...

A team from UNIGE and HUG has discovered a subgroup of immune cells particularly involved in the disease, opening the way to ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Back to Healio March is Multiple Sclerosis Awareness ...

Share on Pinterest A recent study reports that starting treatment at the first signs of MS symptoms could help slow disease progression. Jennifer Blount/Getty Images A recent study finds getting ...

An insurance company repeatedly denied a Wisconsin woman coverage for a medication her doctor prescribed to treat her ...